Semnur Pharmaceuticals SMNR
OTC SMNR
$0.37 +0.00 (+0.27%)
As of: Oct 23, 2026 · 12:01 PM EDT

Semnur Pharmaceuticals (SMNR) Cash from Investing Activities (2023)

Updated

Semnur Pharmaceuticals (SMNR) recorded Cash from Investing Activities of $43.43 million in FY2024, up 9.4% from $39.71 million in FY2023.

Analysis

Semnur Pharmaceuticals (SMNR) Cash from Investing Activities (2023) Analysis & Trends

  • Per Business Quant data, SMNR's Cash from Investing Activities was $39.71 million in FY2023 and -$84.15 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn -2.71 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -1.20 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn -2.91 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -10.35 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 2.11 Bn
10 Semnur Pharmaceuticals 84.49 Mn 84.22 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 40.54 Mn
API Access

Semnur Pharmaceuticals Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=SMNR&period=max&api_key=YOUR_API_KEY